Generex Biotechnology Current Ratio 2006-2019 | GNBT

Generex Biotechnology current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Generex Biotechnology Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-04-30 $0.00B $0.03B 0.13
2019-01-31 $0.01B $0.06B 0.10
2018-07-31 $0.00B $0.03B 0.05
2018-04-30 $0.00B $0.03B 0.07
2018-01-31 $0.00B $0.03B 0.09
2017-10-31 $0.00B $0.02B 0.11
2017-07-31 $0.00B $0.02B 0.12
2017-04-30 $0.00B $0.02B 0.17
2017-01-31 $0.00B $0.02B 0.01
2016-10-31 $0.00B $0.01B 0.00
2016-07-31 $0.00B $0.01B 0.00
2016-04-30 $0.00B $0.01B 0.01
2016-01-31 $0.00B $0.01B 0.00
2015-10-31 $0.00B $0.01B 0.01
2015-07-31 $0.00B $0.01B 0.10
2015-04-30 $0.00B $0.01B 0.12
2015-01-31 $0.00B $0.01B 0.22
2014-10-31 $0.00B $0.01B 0.31
2014-07-31 $0.00B $0.01B 0.42
2014-04-30 $0.00B $0.01B 0.51
2014-01-31 $0.00B $0.01B 0.40
2013-10-31 $0.00B $0.01B 0.15
2013-07-31 $0.00B $0.01B 0.21
2013-04-30 $0.00B $0.01B 0.06
2013-01-31 $0.00B $0.01B 0.14
2012-10-31 $0.00B $0.01B 0.02
2012-07-31 $0.00B $0.01B 0.05
2012-04-30 $0.00B $0.01B 0.17
2012-01-31 $0.00B $0.01B 0.22
2011-10-31 $0.00B $0.01B 0.21
2011-07-31 $0.00B $0.01B 0.40
2011-04-30 $0.01B $0.01B 0.70
2011-01-31 $0.01B $0.01B 1.12
2010-10-31 $0.01B $0.01B 1.29
2010-07-31 $0.02B $0.01B 2.00
2010-04-30 $0.02B $0.01B 2.35
2010-01-31 $0.03B $0.01B 2.32
2009-10-31 $0.03B $0.01B 3.20
2009-07-31 $0.02B $0.01B 1.87
2009-04-30 $0.01B $0.01B 0.71
2009-01-31 $0.01B $0.01B 1.02
2008-10-31 $0.02B $0.01B 1.64
2008-07-31 $0.03B $0.01B 2.02
2008-04-30 $0.04B $0.01B 2.96
2008-01-31 $0.02B $0.01B 3.58
2007-10-31 $0.03B $0.01B 4.02
2007-07-31 $0.04B $0.01B 4.91
2007-04-30 $0.04B $0.01B 5.99
2007-01-31 $0.05B $0.01B 8.64
2006-10-31 $0.05B $0.01B 9.78
2006-07-31 $0.05B $0.01B 8.76
2006-04-30 $0.04B $0.01B 8.23
2006-01-31 $0.02B $0.01B 2.50
2005-10-31 $0.01B $0.01B 1.54
2005-07-31 $0.00B $0.01B 0.20
2005-04-30 $0.00B $0.01B 0.16
2005-01-31 $0.00B $0.01B 0.39
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.028B $0.006B
Generex Biotechnology Corporation provides research, development, and commercialization of drug delivery systems and technologies. The company's products include Generex Oral-lyn, Glucose RapidSpray, BaBOOM Energy Spray and Crave-NX. It markets its products primarily in Ecuador, Canada, and the United States. Generex Biotechnology Corporation is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.340B 10.01
Zoetis (ZTS) United States $59.218B 35.42
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.220B 40.92
Grifols, S.A (GRFS) Spain $15.628B 20.48
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.519B 19.81
Neurocrine Biosciences (NBIX) United States $10.262B 484.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.752B 17.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.480B 10.83
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $7.643B 31.09
IPSEN SA ADR (IPSEY) France $7.310B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.443B 97.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.026B 18.07
FibroGen (FGEN) United States $4.157B 122.15
United Therapeutics (UTHR) United States $4.114B 0.00
Nektar Therapeutics (NKTR) United States $3.833B 0.00
Sage Therapeutics (SAGE) United States $3.761B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.591B 13.13
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.941B 0.00
ArQule (ARQL) United States $2.413B 0.00
Heron Therapeutics (HRTX) United States $2.302B 0.00
Zogenix (ZGNX) United States $2.136B 0.00
Xencor (XNCR) United States $2.127B 64.65
Portola Pharmaceuticals (PTLA) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.979B 63.10
ChemoCentryx (CCXI) United States $1.932B 0.00
Tilray (TLRY) Canada $1.903B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.899B 56.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.721B 0.00
USANA Health Sciences (USNA) United States $1.654B 17.64
Corcept Therapeutics (CORT) United States $1.527B 18.56
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.507B 10.29
Enanta Pharmaceuticals (ENTA) United States $1.295B 29.58
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.196B 0.00
Karyopharm Therapeutics (KPTI) United States $1.068B 0.00
Endo (ENDP) Ireland $1.066B 1.96
Radius Health (RDUS) United States $1.034B 0.00
Aerie Pharmaceuticals (AERI) United States $1.024B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.983B 0.00
Flexion Therapeutics (FLXN) United States $0.795B 0.00
Akebia Therapeutics (AKBA) United States $0.755B 0.00
Dermira (DERM) United States $0.702B 0.00
Collegium Pharmaceutical (COLL) United States $0.694B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.535B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Ardelyx (ARDX) United States $0.470B 0.00
Organogenesis Holdings (ORGO) United States $0.445B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.445B 54.00
BioSpecifics Technologies Corp (BSTC) United States $0.440B 18.98
BioCryst Pharmaceuticals (BCRX) United States $0.439B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.436B 0.00
Harpoon Therapeutics (HARP) United States $0.435B 0.00
Molecular Templates (MTEM) United States $0.413B 0.00
Indivior (INVVY) United States $0.412B 1.49
OptiNose (OPTN) United States $0.393B 0.00
Recro Pharma (REPH) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.375B 0.00
DURECT (DRRX) United States $0.371B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.30
Siga Technologies (SIGA) United States $0.369B 8.43
Corbus Pharmaceuticals Holdings (CRBP) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.312B 0.00
Jounce Therapeutics (JNCE) United States $0.306B 4.09
KalVista Pharmaceuticals (KALV) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.272B 0.00
GlycoMimetics (GLYC) United States $0.267B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Concordia (CXRXF) Canada $0.215B 0.00
Concert Pharmaceuticals (CNCE) United States $0.210B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 32.00
AcelRx Pharmaceuticals (ACRX) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Aquestive Therapeutics (AQST) United States $0.168B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
CV Sciences (CVSI) United States $0.129B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.089B 0.00
Capnia (SLNO) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 23.91
Oasmia Pharmaceutical AB (OASMY) Sweden $0.079B 0.00
Champions Oncology (CSBR) United States $0.078B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Natural Alternatives (NAII) United States $0.058B 14.55
Genocea Biosciences (GNCA) United States $0.058B 0.00
Novan (NOVN) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Mast Therapeutics (SVRA) United States $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
IsoRay (ISR) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Shineco (TYHT) China $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00